Atlas Trials

Study of Triheptanoin for the Prevention of Hypoglycemia in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)

Clinical trial NCT06067802 · WITHDRAWN

Trial details

NCT number
NCT06067802
Sponsor
Jerry Vockley, MD, PhD
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Medium-chain Acyl-CoA Dehydrogenase Deficiency
Start date
2026-08-01
Primary completion
2028-08-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.